Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
2017 · Journal of Clinical Oncology · 546 citations
https://doi.org/10.1200/jco.2017.75.2311
C
Christopher S. Lathan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
7.0K
Citations
35
h-index
60
i10-index
Christopher S. Lathan is an academic researcher from Harvard University. The author has contributed to research in topics: Global Cancer Incidence and Screening & Economic and Financial Impacts of Cancer & Lung Cancer Treatments and Mutations. The author has an h-index of 35, co-authored 137 publications.
ORCID: 0000-0003-4549-3040Papers by this author
worksClinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
2012 · Clinical Cancer Research · 397 citations
https://doi.org/10.1158/1078-0432.ccr-12-1153
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
2023 · JAMA · 125 citations
https://doi.org/10.1001/jama.2023.7843
Restructuring lung cancer care to accelerate diagnosis and treatment in patients vulnerable to healthcare disparities using an innovative care model
2023 · MethodsX · 7 citations
https://doi.org/10.1016/j.mex.2023.102338
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia
2023 · Blood Cancer Journal · 2 citations
https://doi.org/10.1038/s41408-023-00964-x
MA04.03 Bringing Equity to the Community: The Dana-Farber Cancer Care Equity Program's Lung Cancer Screening Initiative
2024 · Journal of Thoracic Oncology · 0 citations
https://doi.org/10.1016/j.jtho.2024.09.116
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat